216 related articles for article (PubMed ID: 33353357)
41. Evaluation of an enhanced service for medication review with follow up in Swiss community pharmacies: Pre-post study protocol.
Amador-Fernández N; Escaith M; Simi E; Quintana-Bárcena P; Berger J
PLoS One; 2023; 18(10):e0292037. PubMed ID: 37847695
[TBL] [Abstract][Full Text] [Related]
42. Identify and categorize drug-related problems in hospitalized surgical patients in China.
Qu C; Meng L; Wang N; Chen Y; Yang X; Wang J; Sun S; Qiu F
Int J Clin Pharm; 2019 Feb; 41(1):13-17. PubMed ID: 30610549
[TBL] [Abstract][Full Text] [Related]
43. Impact of providing psychiatry specialty pharmacist intervention on reducing drug-related problems among children with autism spectrum disorder related to disruptive behavioural symptoms: A prospective randomized open-label study.
Wongpakaran R; Suansanae T; Tan-Khum T; Kraivichian C; Ongarjsakulman R; Suthisisang C
J Clin Pharm Ther; 2017 Jun; 42(3):329-336. PubMed ID: 28317138
[TBL] [Abstract][Full Text] [Related]
44. Pharmacists' interventions on 2 years of drug monitoring in an oncology pediatric inpatient ward.
Agnol RD; Dos Santos MT; Michalowski MB; Einsfeld L
J Oncol Pharm Pract; 2022 Dec; 28(8):1754-1762. PubMed ID: 34605321
[TBL] [Abstract][Full Text] [Related]
45. Pharmacists' performance of clinical interventions during adherence support medication reviews.
Hatah E; Tordoff J; Duffull SB; Braund R
Res Social Adm Pharm; 2014; 10(1):185-94. PubMed ID: 23688540
[TBL] [Abstract][Full Text] [Related]
46. The effect of the clinical pharmacist in minimizing drug-related problems and related costs in the intensive care unit in Turkey: A non-randomized controlled study.
Ayhan YE; Karakurt S; Sancar M
J Clin Pharm Ther; 2022 Nov; 47(11):1867-1874. PubMed ID: 36196779
[TBL] [Abstract][Full Text] [Related]
47. Characterization of drug-related problems and associated factors in ambulatory patients in China.
Wang X; Yang J; Yu X; Wang Z; Wang H; Liu L
J Clin Pharm Ther; 2020 Oct; 45(5):1058-1065. PubMed ID: 32516504
[TBL] [Abstract][Full Text] [Related]
48. Clinical pharmacist interventions in managing drug-related problems in hospitalized patients with neurological diseases.
Ali MAS; Khedr EMH; Ahmed FAH; Mohamed NNE
Int J Clin Pharm; 2018 Oct; 40(5):1257-1264. PubMed ID: 29922968
[TBL] [Abstract][Full Text] [Related]
49. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
[TBL] [Abstract][Full Text] [Related]
50. Drug related problems identified by clinical pharmacist at the Internal Medicine Ward in Turkey.
Abunahlah N; Elawaisi A; Velibeyoglu FM; Sancar M
Int J Clin Pharm; 2018 Apr; 40(2):360-367. PubMed ID: 29380236
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of pharmacist interventions and commonly used medications in the geriatric ward of a teaching hospital in Turkey: a retrospective study.
Ertuna E; Arun MZ; Ay S; Koçak FÖK; Gökdemir B; İspirli G
Clin Interv Aging; 2019; 14():587-600. PubMed ID: 30962679
[TBL] [Abstract][Full Text] [Related]
52. Drug-Related Problems on a Palliative Care Unit.
Rémi C; Bauer D; Krumm L; Bausewein C
J Pain Palliat Care Pharmacother; 2021 Dec; 35(4):264-272. PubMed ID: 34460343
[TBL] [Abstract][Full Text] [Related]
53. Impact of a multidisciplinary approach involving clinical pharmacist on resolving drug related problems in chronic kidney patients: a prospective interventional study.
Pehlivanli A; Eyupoglu S; Basgut B; Erturk S; Ozcelikay AT
BMC Nephrol; 2023 May; 24(1):149. PubMed ID: 37237342
[TBL] [Abstract][Full Text] [Related]
54. Pharmacist-led medication reviews in pre-dialysis and dialysis patients.
van Berlo-van de Laar IRF; Sluiter HE; Riet EV'; Taxis K; Jansman FGA
Res Social Adm Pharm; 2020 Dec; 16(12):1718-1723. PubMed ID: 32111533
[TBL] [Abstract][Full Text] [Related]
55. A retrospective analysis of drug-related problems documented in a national database.
Westerlund T; Gelin U; Pettersson E; Skärlund F; Wågström K; Ringbom C
Int J Clin Pharm; 2013 Apr; 35(2):202-9. PubMed ID: 23187961
[TBL] [Abstract][Full Text] [Related]
56. Drug-related problems vary with medication category and treatment duration in Taiwanese heart failure outpatients receiving case management.
Hsu WT; Shen LJ; Lee CM
J Formos Med Assoc; 2016 May; 115(5):335-42. PubMed ID: 26774679
[TBL] [Abstract][Full Text] [Related]
57. Beliefs influencing community pharmacists' interventions with chronic kidney disease patients: A theory-based qualitative study.
Quintana-Bárcena P; Lalonde L; Lauzier S
Res Social Adm Pharm; 2019 Feb; 15(2):145-153. PubMed ID: 29709530
[TBL] [Abstract][Full Text] [Related]
58. Development of an aggregated system for classifying causes of drug-related problems.
Basger BJ; Moles RJ; Chen TF
Ann Pharmacother; 2015 Apr; 49(4):405-18. PubMed ID: 25614526
[TBL] [Abstract][Full Text] [Related]
59. Qualitative and quantitative research of medication review and drug-related problems in Hungarian community pharmacies: a pilot study.
Szilvay A; Somogyi O; Meskó A; Zelkó R; Hankó B
BMC Health Serv Res; 2019 May; 19(1):282. PubMed ID: 31053135
[TBL] [Abstract][Full Text] [Related]
60. Drug-Related Problems and Pharmacists' Interventions in Hypertensive Outpatients: A Multicenter Prospective Study in 3 Vietnamese Hospitals.
Huynh BH; Nathisuwan S; Tragulpiankit P; Nguyen VD; Huynh NH; Vu TLA; Huynh LTH; Vo HT
J Pharm Technol; 2023 Dec; 39(6):259-268. PubMed ID: 37974593
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
